S U M M A R Y Somatostatin released from capsaicin-sensitive sensory nerves of the lung during endotoxin-induced murine pneumonitis inhibits inflammation and hyperresponsiveness, presumably via somatostatin receptor subtype 4 (sst 4 ). The goal of the present study was to identify sst 4 receptors in mouse and human lungs and to reveal its inflammation-induced alterations with real-time quantitative PCR, Western blot, and immunohistochemistry. In non-inflamed mouse and human lungs, mRNA expression and immunolocalization of sst 4 are very similar. They are present on bronchial epithelial, vascular endothelial, and smooth-muscle cells. The sst 4 receptor protein in the mouse lung significantly increases 24 hr after intranasal endotoxin administration as well as in response to 3 months of whole-body cigarette smoke exposure, owing to the infiltrating sst 4 -positivite mononuclear cells and neutrophils. In the chronically inflamed human lung, the large number of activated macrophages markedly elevate sst 4 mRNA levels, although there is no change in acute purulent pneumonia, in which granulocytes accumulate. Despite mouse granulocytes, human neutrophils do not show sst 4 immunopositivity. We provide the first evidence for the expression, localization, and inflammation-induced alterations of sst 4 receptors in murine and human lungs. Inasmuch as tissue distribution of this receptor is highly similar, extrapolation of murine experimental results to human conditions might be possible.
S U M M A R Y Somatostatin released from capsaicin-sensitive sensory nerves of the lung during endotoxin-induced murine pneumonitis inhibits inflammation and hyperresponsiveness, presumably via somatostatin receptor subtype 4 (sst 4 ). The goal of the present study was to identify sst 4 receptors in mouse and human lungs and to reveal its inflammation-induced alterations with real-time quantitative PCR, Western blot, and immunohistochemistry. In non-inflamed mouse and human lungs, mRNA expression and immunolocalization of sst 4 are very similar. They are present on bronchial epithelial, vascular endothelial, and smooth-muscle cells. The sst 4 receptor protein in the mouse lung significantly increases 24 hr after intranasal endotoxin administration as well as in response to 3 months of whole-body cigarette smoke exposure, owing to the infiltrating sst 4 -positivite mononuclear cells and neutrophils. In the chronically inflamed human lung, the large number of activated macrophages markedly elevate sst 4 mRNA levels, although there is no change in acute purulent pneumonia, in which granulocytes accumulate. Despite mouse granulocytes, human neutrophils do not show sst 4 immunopositivity. We provide the first evidence for the expression, localization, and inflammation-induced alterations of sst 4 receptors in murine and human lungs. Inasmuch as tissue distribution of this receptor is highly similar, extrapolation of murine experimental results to human conditions might be possible. (J Histochem Cytochem 57:1127 -1137 , 2009 K E Y W O R D S airway inflammation endotoxin exposure immunohistochemistry mouse and human lung pathology pulmonary macrophage reverse transcriptase polymerase chain reaction somatostatin Western blot WE HAVE RECENTLY PROVIDED several lines of evidence that in the murine model of endotoxin lipopolysaccharide (LPS)-induced airway inflammation, somatostatin [somatotropin release-inhibiting factor (SRIF)] is released from capsaicin-sensitive sensory nerves of the lung. Somatostatin gets into the systemic circulation and inhibits the progress of the inflammatory reaction as well as bronchial hyperreactivity ). This potent somatostatin-mediated counterregulatory mechanism in the airways was very similar to that observed in several other inflammation and pain models (Szolcsányi et al. 1998a,b; Helyes et al. 2004; Pintér et al. 2006) .
Somatostatin is widely distributed throughout the body in 14-and 28-amino acid-containing forms (Gamse et al. 1981; Patel et al. 1995; ten Bokum et al. 2000) and exerts a wide range of actions (ten Bokum et al. 2000; Pintér et al. 2006 ). These effects are mediated via five different somatostatin receptor subtypes (sst 1 -sst 5 ). In general, the somatostatin receptor family can be divided into two main groups on the basis of their sequence similarities and binding profile of synthetic analogs: the SRIF 1 group comprises sst 2 , sst 3 , and sst 5 receptors, whereas the SRIF 2 group contains sst 1 and sst 4 receptors (Hoyer et al. 1995; Reisine and Bell 1995) . Several data indicate that receptors in the SRIF 1 group mediate the endocrine and antiproliferative effects of somatostatin. Our previous results revealed that the SRIF 2 group is likely to be responsible for the anti-inflammatory and anti-nociceptive actions (Helyes et al. 2000 (Helyes et al. ,2001 Szolcsányi et al. 2004) . SRIF 2 -selective agonists such as the heptapeptide TT-232 (Helyes et al. 2001 (Helyes et al. ,2003 or the highly sst 4 -selective peptidomimetic ligand J-2156 proved to be effective inhibitors of inflammatory and nociceptive processes ). The sst 4 receptor, similarly to the other four sst subtypes, belongs to the G protein-coupled receptor family (Hoyer et al. 1995) ; its activation inhibits adenylate cyclase and, consequently, cAMP/protein kinase A via pertussis toxin-sensitive guanosine triphosphate binding proteins (G i proteins) (Patel et al. 1995) , opens various K 1 channels, and inhibits voltage-gated Ca 21 channels. In addition, sst 4 receptor agonists enhance signaling through mitogen-activated protein kinase, phospholipase C and phospholipase A 2 , and activate/inhibit phosphotyrosine phosphatases (Weckbecker et al. 2003) .
Although previous results have suggested that the anti-inflammatory actions of endogenous somatostatin are mediated predominantly via sst 4 receptors in various tissues, including the airways (Elekes et al. 2008) , direct evidence supporting this view has not been provided, owing to the lack of selective sst 4 antagonists. Furthermore, as compared with other receptor subtypes, there are relatively few data in the literature on the localization of sst 4 receptors in general. In the rat, sst 4 mRNA can be detected in the posterior iris epithelium and ciliary body (Mori et al. 1997) , in several brain regions (Fehlmann et al. 2000) , on peripheral blood mononuclear cells and thymocytes (ten Bokum et al. 1999; Lichtenauer-Kaligis et al. 2004) , in vascular smoothmuscle cells, and in the lung (Schloos et al. 1997; Pintér et al. 2006) . In humans, its immunohistochemical localization was found on exocrine gland cells and lymphocytes (Taniyama et al. 2005) , as well as in the cytoplasm of tubular epithelial cells, podocytes, and mesangial cells in the kidney, where a marked upregulation was seen in response to inflammation (Bhandari et al. 2008) . Sst 4 mRNA was detected on human vascular endothelial cells (Curtis et al. 2000) . In the mouse, however, its expression has only been shown on peripheral blood mononuclear cells, in the spleen, thymus, and bone marrow (Lichtenauer-Kaligis et al. 2004) . We are lacking direct evidence for the localization of sst 4 receptors in the lung, and it is also unknown how sst 4 expression correlates with pulmonary inflammation.
Inasmuch as the function of sst 4 during inflammation in the human lung cannot be studied directly, a model is essential to understanding the pathophysiological role of this receptor in inflammatory processes. Mouse models appear to be the most versatile and easily accessible, for example, with the help of creating genetically manipulated animals. However, animal models can only be use-ful if data gained in the experiments can be extrapolated to human conditions.
Because there is only limited information in the present literature concerning the presence and cellular distribution of the sst 4 receptor in pulmonary tissues, the first aim of the present study was to determine quantitatively and qualitatively the expression and localization patterns of sst 4 in mouse and human lungs. For this purpose, immunohistochemical and Western blot analysis, as well as RT-PCR for measuring sst 4 mRNA, were used. Second, by comparing the alterations of sst 4 receptor expression in experimentally induced acute and chronic murine lung inflammation and inflamed human pulmonary tissues, we aimed to investigate whether results obtained in airway inflammation models in mice can be reliably extrapolated to humans.
Materials and Methods
Animal Studies, Airway Inflammation Models Six-week-old male C57BL/6 mice (20-25 g; n56-10/ group) were used for both models and were bred and kept in the animal house of the department of pharmacology and pharmacotherapy at the University of Pécs. The animals were provided with standard rodent chow and water ad libitum.
Endotoxin-induced Subacute Pneumonitis in Mice
Subacute airway inflammation was evoked by 60 ml intranasally applied Escherichia coli (serotype: 083) LPS (167 mg/ml dissolved in sterile PBS; Sigma, St. Louis, MO) and mice were sacrificed 24 hr later. Data showing that intranasal administration of this LPS dose evoked maximal inflammation (neutrophil accumulation and inflammatory cytokine production) 24 hr after its instillation served as the basis for choosing this time point. The same volume of sterile PBS was administered to control mice regarded as intact (non-inflamed) animals (Elekes et al. ,2008 Helyes et al. 2007 Helyes et al. ,2009 .
Cigarette Smoke-induced Chronic Bronchitis in Mice
Mice were exposed to 3R4F research cigarette smoke (College of Agriculture, University of Kentucky; Lexington, KY) with the help of a manual smoking system (TE2; Teague Enterprises, Woodland, CA). Whole-body smoke exposure was performed twice a day for 40 min in the closed chamber of the equipment (two cigarettes per occasion for six mice in the cage) for 3 months. Cigarettes burned down within 10 min; then the ventilator was switched off for 30 min, and the chamber was ventilated afterward for 10 min. The average concentration of the total suspended particles in the chamber was 70 mg/m 3 .
At the end of both experiments, the mice were anesthesized with ketamine-xylazine (5 mg/kg intraperi-1128 Varecza, Elekes, László, Perkecz, Pintér, Sándor, Szolcsányi, Keszthelyi, Szabó, Sándor, Molnár, Szántó, Pongrácz, Helyes toneally-100 mg/kg intramuscularly), and killed by cervical dislocation, and the lungs were excised. Each lung was cut into three parts; the upper half of the left lung was put into RNAlater (Qiagen; Hilden, Germany) for molecular biological studies, the lower half was placed in 1 ml lysis buffer for Western blot analysis, and the whole right lung sample was fixed in 4% buffered formaldehyde (Szkarabeusz Ltd.; Pécs, Hungary) for immunohistochemical examination.
Human Samples
Samples were obtained from 11 patients undergoing lung operations from the intact and inflamed parts surrounding the tumor. The surgical procedure was lobectomy in eight cases, pulmectomy in one case, and excision in two cases (non-malignant diseases). The non-inflamed specimens were obtained from a distant part of the resected lung lobe (or excised area) and appeared macroscopically to be obviously healthy, and subsequently proven to be so microscopically. Perifocal biopsies were performed to obtain inflamed but nontumor lung samples; this was verified by subsequent histopathological examinations. Permission was obtained from the local ethical committee, and patients signed the informed consent form. Tissues were processed and stored similarly to the protocol described for the mouse samples.
Determination of Sst 4 Receptor mRNA in the Lung
Lung samples placed into 1 ml RNAlater solution were stored at 280C if not processed immediately. Total RNA was isolated using the GenElute Mammalian Total RNA Miniprep Kit (Sigma). RNA yield purity was determined by spectrophotometry (Nanodrop; Bio-Science Ltd., Budapest, Hungary) and electrophoresis on 1% agarose gel. Then cDNA was prepared from 1 mg total RNA with MuMLV reverse transcriptase (Abgene Ltd.; Epsom, UK), which has been proven to introduce no bias into the original balance of different RNA sequences. Amounts of cDNAs encoding the sst 4 receptor and the housekeeping endogenous control 18S rRNA for comparison were measured by quantitative real-time PCR using TaqMan assays (Applied Biosystems, Inc., Foster City, CA; mouse sst 4 assay ID: Mm00436710_s1, human sst 4 assay ID: Hs012566620_s1, and eukaryotic 18S RNA: 4352930E). Each PCR reaction was performed in triplicate using Taqman Universal PCR Master Mix on an ABI 7500 real-time PCR system (Applied Biosystems). The ABI 7500 PCR program consisted of an initial step of 50C for 2 min, then 95C for 10 min, followed by a denaturation step at 95C for 15 sec and 40 cycles of amplification for 15 sec at 95C and 1 min at 60C. To confirm the purity and size of the PCR prod-ucts, the reactions were analyzed by electrophoresis, and the results were evaluated by QuantityOne software (BioRad; Hercules, CA). TaqMan data were analyzed by the standard curve method according to the manufacturer's recommendation (ABI 7500 manual). Serial dilutions of total mRNA isolated from the lung (33 ng, 66.5 ng, 125 ng, 250 ng per reaction) were run on 96-well RT-PCR plates (Applied Biosystems) for all TaqMan probes in three parallels. Standard curves were generated for each transcript, and expression levels were normalized to the housekeeping gene of S18 mRNA of the same sample. The parameters of the standard curves (slope, intercept, and R 2 ), as well as the mean mRNA quantities in the samples, were calculated automatically by the 7500 system SDS software (Applied Biosystems).
Measurement of the Sst 4 Receptor Protein in the Lung With Western Blot
The mouse lung was homogenized in ice-cold lysis buffer (50 mM HEPES, 10 mM sodium pyrophosphate, 10 mM EDTA, 100 mM sodium fluoride, 10% glycerol, and 1% Triton X-100) containing protease inhibitor cocktail (1:100) (Sigma). Whole-cell lysates were resolved by SDS-PAGE on 10% acrylamide gels after adding equal amounts of 23 sample buffer (125 mM Tris, 4% SDS, 10% glycerol, 0.006% bromo-phenol blue, and 10% mercaptoethanol). The gels were blotted for 2 hr to nitrocellulose membranes using a wet transfer procedure on BioRad MiniProtean electrophoresis equipment. To saturate nonspecific binding sites, the blots were soaked in blocking buffer (3% dry milk, 10 mM Tris, 100 mM sodium chloride, and 0.1% Tween 20, pH 7.4). For washing the blots, washing buffer (TBS-T) was used (10 mM Tris, 100 mM sodium chloride, and 0.1% Tween-20, pH 7.4). The membranes were incubated for 2 hr at room temperature with 5003 dilution of the primary sst 4 antibody [goat polyclonal anti-sst 4 (P-15) antibody, Lot# G-121; Santa Cruz Biotechnology, Santa Cruz, CA], then washed three times for 5 min with TBS-T. Specific binding of the primary antibody was detected with horseradish peroxidase (HRP)-conjugated donkey anti-goat IgG (Lot# E-3106; Santa Cruz Biotechnology). Western blot visualization was performed by enhanced chemiluminescence as described in the manufacturer's instructions (SuperSignal West Pico Chemiluminescent substrate; Pierce, Rockford, IL) by exposure to XAR-5 X-ray film (Kodak Laboratories; New York, NY). For stripping the blots, Restore Stripping Buffer (Pierce) was used.
To prove the equal protein loading we used 10,0003 dilution of monoclonal mouse anti-b-actin antibody Lot# 097K4834 (Sigma-Aldrich, St. Louis, MO) and 20003 dilution of HRP-conjugated goat anti-mouse IgG (Lot#0001; Hunnavix Ltd., Nagygörbő, Hun-Expression of Sst 4 in Mouse and Human Lungs 1129 gary). Blots were analyzed with densitometry with the QuantityOne software (BioRad).
Immunohistochemical Detection of the Sst 4 Receptor
Protein in the Lung Lung specimens were fixed in 4% buffered formaldehyde for 24 hr and embedded in paraffin, and 5-7-mm sections were made with a microtome. The antigen was revealed by incubating the slides in acidic (pH 6) citrate buffer in a microwave oven three times for 5 min (750 W). The endogenous peroxidase activity of the tissue was inhibited by a 20-min incubation with 3% hydrogen peroxide. For the prevention of nonspecific binding of the secondary antibody, preincubation was performed with normal goat serum for 20 min. The slides were incubated with a 1:100 dilution of rabbit polyclonal anti-sst 4 antibody (for the mouse lung, ASR-004 Lot#: AN-01, Alomone Labs Ltd., Jerusalem, Israel; for the human lung, LSA4148, MBL International Corporation, Woburn, MA) for 1 hr and then with the secondary HRP-conjugated EnVision antirabbit secondary antibody (Dako-Cytomation; Dako North America, Inc., Carpinteria, CA) for 1 hr. Finally, immunolocalization of the sst 4 receptor was detected by DAB development for 10 min, and nuclear staining was performed with hematoxylin. The specificity of the immunohistochemical reaction was confirmed by the lack of staining after preincubation of the primary antibody with an equal amount of the control peptide antigen included in the package of the primary antibody (Lot#AG-01; Alomone Labs), as well as by lack of immunopositivity after using only the secondary antibody without the primary antibody. Furthermore, staining was not observed in tissues of sst 4 receptor knockout mice.
Statistical Analysis
Each RT-PCR and Western blot analysis was repeated at least three times, and the data were averaged. Values for all measurements were expressed as means 6 SEM of n56-11 samples in both series of studies. In the mouse experiments, two-tailed Student's t-tests, and in the human samples, one-tailed Student's t-tests were used for unpaired and paired comparisons, respectively, to perform statistical analyses. In all cases, p,0.05 was considered to be significant.
Ethical Considerations
All animal experimental procedures were carried out according to the 1998/XXVIII Act of the Hungarian Parliament on Animal Protection and Consideration Decree of Scientific Procedures of Animal Experiments (243/ 1988) and complied with the recommendations of the Helsinki Declaration. The studies were approved by the ethics committee on animal research of the Univer- Varecza, Elekes, László, Perkecz, Pintér, Sándor, Szolcsányi, Keszthelyi, Szabó, Sándor, Molnár, Szántó, Pongrácz, Helyes sity of Pécs according to the ethical codex of animal experiments, and permission was given (license no. BA 02/ 2000-11-2006) . For the examination of the human lungs, permission was given by the ethical committee of the University of Pécs, and all patients signed the informed consent forms. receptor mRNA is present in total mouse lung extracts. Subacute interstitial pulmonary inflammation 24 hr after intranasal LPS administration and three months of whole-body cigarette smoke exposure slightly, but not significantly, increased sst 4 mRNA concentration, compared with its basal expression measured in noninflamed lungs ( Figure 1A) .
Results

Studies on Mouse Pulmonary Tissues
Expression of the Sst 4 Receptor Protein in Total
Extracts of Intact and Inflamed Mouse Lung Tissues. Detection of the sst 4 receptor at the protein level confirmed its presence in the mouse lung. Western blot analysis revealed that both subacute and chronic inflammatory reactions induced by intranasal LPS administration and chronic cigarette smoke exposure, respectively, significantly increased the amount of sst 4 receptors in the lung, compared with non-inflamed controls ( Figures 1B and 1C) .
Tissue-and Cell-specific Localization of Sst 4 Receptors in the Mouse Lung. Immunolocalization of the sst 4 receptor protein in the intact lung was clearly detected on the bronchial epithelial cells, particularly on their luminal surfaces, on vascular as well as bronchial/ bronchiolar smooth-muscle cells, vascular endothelial cells, and fibrocytes in the interalveolar septal regions (Figures 2A and 2B) . One day after intranasal endotoxin treatment, a marked infiltration of mononuclear cells and neutrophils was observed predominantly in the peribronchial/perivascular spaces, indicating the development of subacute interstitial pneumonitis. Both accumulating mononuclear cell types (activated macrophages and lymphocytes), as well as neutrophils, stained for the sst 4 receptor (Figures 2C and 2D ). In the lungs of mice exposed to cigarette smoke for 3 months (for 40 min twice a day), typical signs of chronic bronchitis/bronchiolitis were seen. The interalveolar septum was desintegrated, the bronchiolar epithelial layer was irregular, and epithelial damage and hyperplasia could simultaneously be observed. Large numbers of sst 4 receptor-expressing activated macrophages infiltrated the alveolar spaces and dominated the picture, but there were also sst 4 -positive lymphocytes and a few granulocytes (Figures 2E and 2F) .
Studies on Human Pulmonary Tissues
Expression of Sst 4 Receptor mRNA in Intact and Inflamed Human Lungs. Lung samples were obtained both from macroscopically inflamed and intact sites of 11 patients undergoing operations: nine tumor resections and two non-malignant cases (aspergilloma and tuberculoma). RT-PCR data have revealed that the sst 4 receptor mRNA is present in the non-inflamed human lung. Its relative expression, compared with the housekeeping S18 mRNA, was 1.9 6 0.19, which was an expression level very similar to that found in mice. A significant increase in sst 4 receptor mRNA levels (ranging between 2.78-fold and 30.07-fold) was observed in the inflamed specimens compared with the respective intact tissue counterparts of eight patients. Clinical history, preoperative bronchoscopy, and histological diagnosis of the inflamed pulmonary samples of these patients have shown characteristic features of chronic bronchitis. These patients (except Patient 7) were heavy smokers undergoing surgery for relatively small peripheral primary adenocarcinomas (Patients 4, 6, 8, and 10) , metastatic tumors (Patient 1, hepatocellular carcinoma; Patient 5, renal carcinoma), or nonneoplastic diseases (Patient 7, aspergilloma; Patient 11, tuberculoma) . The presence of chronic inflammation was supported by a large number of infiltrating mononuclear cells (desquamating interstitial pneumonitis, follicular bronchiolitis). The extent of sst 4 mRNA increase in the inflamed lung was in good correlation with the severity of the chronic inflammatory reaction seen on histology. Results of the two patients without malignancies revealed changes in sst 4 expression very similar to those found in the other cases of chronic inflammation.
In contrast, in the inflamed pulmonary samples obtained from Patients 2, 3, and 9, who had acute/subacute pneumonia with a marked accumulation of granulocytes, no change was observed in sst 4 receptor mRNA expression in the inflamed and intact sites. Patients 2 1132 Varecza, Elekes, László, Perkecz, Pintér, Sándor, Szolcsányi, Keszthelyi, Szabó, Sándor, Molnár, Szántó, Pongrácz, Helyes and 3 underwent surgery for large planocellular cancers in the central lung regions; Patient 9 had mixedtype (95% planocellular cancer, 5% adenocarcinoma) in the right lower lobe. Acute purulent inflammation was observed in the peripheral sites where atelectasia developed ( Figure 3 ; Table 1 ).
Localization of Sst 4 Receptor Protein in Intact and
Inflamed Human Lungs. Localization of the sst 4 receptor protein in the intact human lung ( Figures 4A  and 4D ) using immunohistochemistry could be detected in smooth-muscle cells ( Figures 5A and 5C ), bronchial and bronchiolar epithelial cells ( Figure 5B) , and vascular endothelial cells ( Figure 5C ), very similar to that observed in mice. The left three panels of Figure 4 show sst 4 receptor immunostaining of Patient 1, who underwent surgery for a relatively small solitary metastasis of a liver cancer in the peripheral region of the lung. Compared with the intact site ( Figure 4A) , a large number of sst 4 -immunopositive activated macrophages and some lymphocytes can be seen in the intraalveolar region of the chronically inflamed lung ( Figures 4B and 4C and Figure 5D ). This image is in perfect correlation with the 30.07-fold elevation of sst 4 mRNA detected in this sample. In the lung specimens obtained from Patient 2, in whom bronchiectasia and a severe acute purulent pneumonia were diagnosed, the bronchial lumen is completely filled with neutrophils that do not express the sst 4 receptor, and there are also a few sst 4 -positive lymphocytes (Figures 4E and 4F) . The small 1.86-fold increase of sst 4 receptor mRNA found in this patient is explained well by this morphological finding.
Discussion
The existence of sst 4 receptors in mammalian tissues was first identified in the rat lung (Schloos et al. 1997 ). This article provided molecular biological evidence that sst 4 was the predominant form of somatostatin receptors found in the rat airways. At that time, subtype-specific antibodies and agonists were not available, and therefore, neither the cell types exhibiting sst 4 , nor its role could be determined. However, the authors emphasized the great need for analyzing the localization and function of sst 4 in the airways (Schloos et al. 1997; Fehlmann et al. 2000) . The present results provide the first immunohistochemical, molecular biological, and Western blot evidence for the expression of sst 4 receptors in mouse and human pulmonary tissues. In intact, non-inflamed lungs, the relative expression of sst 4 mRNA and the localization of this receptor protein are very similar in mice and humans. In both species, sst 4 is predominantly localized on bronchial epithelial and vascular endothelial cells, as well as on bronchial/ vascular smooth-muscle cells and fibrocytes in the interalveolar septal regions. Because most human samples were obtained from patients with malignancies, the influencing effect of the tumor on sst 4 expression even in the macroscopically and microscopically intact distant parts of the removed sections certainly cannot be excluded. However, sst 4 expression in the intact parts 1134 Varecza, Elekes, László, Perkecz, Pintér, Sándor, Szolcsányi, Keszthelyi, Szabó, Sándor, Molnár, Szántó, Pongrácz, Helyes was rather similar in different patients with different cancer types as well as in the two patients without neoplastic disease. Endotoxin-induced murine pneumonitis is a widely used subacute interstitial lung inflammation model with a well-defined mechanism. Mononuclear cells and granulocytes infiltrating predominantly into the peribronchial and perivascular regions secrete inflammatory cytokines, mainly TNF-a and IL-1b (Savov et al. 2002; Elekes et al. 2007 Elekes et al. ,2008 Helyes et al. 2007 ).
The most-relevant model of chronic bronchitis/bronchiolitis is cigarette smoke-evoked experimental inflammation, in which the histopathological changes are very similar to those in human conditions (Wright et al. 2008) . In these models, alterations of sst 4 receptor expression were found to be different at the mRNA and protein levels. The amount of the sst 4 protein markedly increased in the inflamed lung 24 hr after intranasal LPS administration, as well as in response to 3 months of whole-body cigarette smoke exposure, and can be explained by the infiltration of sst 4 -positive macrophages, lymphocytes, and neutrophils. Despite the infiltration of sst 4 -expressing inflammatory cells, which is in correla-tion with the data obtained at the protein level, the sst 4 mRNA concentration did not increase significantly in either subacute or chronic experimental inflammatory conditions. Potential explanations for this discrepancy might be the enhanced mRNA degradation during inflammation, the differences in the turnover rate of the RNA and the protein, several posttranscriptional factors modifying mRNA processing, and/or the fact that the receptors are already on the accumulating inflammmatory cells when they infiltrate the lung. Such virtual contradictions are often found; proteomic studies have demonstrated that the levels of several proteins rarely correlate with the mRNA content of the tissues (Chen et al. 2002) .
We have previously shown in several inflammation models that somatostatin is released from activated capsaicin-sensitive peptidergic sensory nerve endings in response to inflammatory/nociceptive stimuli, and that it can reach the circulation to exert systemic antiinflammatory actions (Szolcsányi et al. 1998a (Szolcsányi et al. ,b,2004 Helyes et al. 2004 ). More recently, this somatostatinmediated counter-regulatory mechanism was also proven in the endotoxin-induced lung inflammation model (Helyes et al. ,2009 ). The wide range of inhibitory actions of somatostatin derived from sensory nerves were suggested to be mediated via sst 4 receptor activation (Szolcsányi et al. 2004; Pintér et al. 2006; Helyes et al. 2007 ) on the basis of potent anti-inflammatory and anti-hyperreactivity effects of synthetic sst 4 receptor agonists in both LPS-induced acute pneumonitis and ovalbumine-evoked chronic asthma models in mice (Elekes et al. 2008) . The present data strongly support these findings; we show a direct increase of sst 4 receptors in response to inflammatory stimuli.
The main difference found between mouse and human tissues is the lack of sst 4 receptors on human neutrophils. This is in agreement with results shown on human peripheral blood granulocytes (Hiruma et al. 1990) , as well as with our unpublished findings on human synovium, colon, and peripheral blood neutrophils. The presence of sst 4 receptors in human macrophages and lymphocytes, and its remarkable upregulation during chronic inflammatory conditions, suggest its potential therapeutic significance.
The presence of somatostatin and sst 4 receptors in the lung is of great pathophysiological importance. Somatostatin has been shown to effectively inhibit the release of pro-inflammatory sensory neuropeptides (Helyes et al. 2001 (Helyes et al. ,2003 Pintér et al. 2006 ) and to modulate the immune system by inhibiting monocytemacrophage functions (Krantic 2000) , immunoglobulin production of B lymphocytes, proliferation and cytokine production of T lymphocytes, and fibrosis (Kolasinski et al. 1992; Pintér et al. 2006; Borie et al. 2008 ). Furthermore, upregulation of somatostatin binding sites in several immune-mediated and inflammatory diseases (ten Bokum et al. 1999 Bokum et al. ,2000 Pintér et al. 2006 ) shows a direct link with the regulation of inflammatory processes.
The present study, which describes a remarkable upregulation of sst 4 receptors during chronic inflammatory conditions in humans, supports the conclusions obtained in mouse experiments Elekes et al. 2008; Helyes et al. 2009 ) and suggests the potential therapeutic significance of synthetic sst 4 receptor agonists as novel tools for the treatment of inflammatory diseases of the airways.
